Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
P/S ratio for Innate Pharma (IPHA)
P/S ratio at the end of 2022: 5.63
According to Innate Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.51693. At the end of 2022 the company had a P/S ratio of 5.63.
P/S ratio history for Innate Pharma from 2006 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 5.63 | -80.71% |
| 2021 | 29.2 | 499.83% |
| 2020 | 4.87 | -28.87% |
| 2019 | 6.85 | 14.91% |
| 2018 | 5.96 | -28.34% |
| 2017 | 8.31 | -40.93% |
| 2016 | 14.1 | -65.41% |
| 2015 | 40.7 | -91.17% |
| 2014 | 461 | 2436% |
| 2013 | 18.2 | 129.2% |
| 2012 | 7.93 | 48.93% |
| 2011 | 5.33 | -47.63% |
| 2010 | 10.2 | -13.41% |
| 2009 | 11.7 | 326.27% |
| 2008 | 2.76 | -37.43% |
| 2007 | 4.40 | -65.45% |
| 2006 | 12.7 |